CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
13 results
Search Results
Now showing 1 - 10 of 13
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis(2023) ;Wilson Bautista-Molano ;Daniel G. Fernández-Ávila ;María Lorena Brance ;María Gabriela Ávila PedrettiRuben Burgos-Vargas3Scopus© Citations 45 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice(2023) ;Alex Aren ;María José Moreta ;Ingrid Ordás ;Agnès Fernández-ClotetBerta Caballol1Scopus© Citations 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, miRNA Landscape in Pathogenesis and Treatment of Vogt–Koyanagi–Harada Disease(2021) ;Fabian Vega-Tapia ;Mario Bustamante ;Rodrigo A. Valenzuela ;Cristhian A. UrzuaLoreto Cuitino<jats:p>miRNAs, one of the members of the noncoding RNA family, are regulators of gene expression in inflammatory and autoimmune diseases. Changes in miRNA pool expression have been associated with differentiation of CD4<jats:sup>+</jats:sup> T cells toward an inflammatory phenotype and with loss of self-tolerance in autoimmune diseases. Vogt–Koyanagi–Harada (VKH) disease is a chronic multisystemic pathology, affecting the uvea, inner ear, central nervous system, and skin. Several lines of evidence support an autoimmune etiology for VKH, with loss of tolerance against retinal pigmented epithelium-related self-antigens. This deleterious reaction is characterized by exacerbated inflammation, due to an aberrant T<jats:sub><jats:italic>H</jats:italic></jats:sub>1 and T<jats:sub><jats:italic>H</jats:italic></jats:sub>17 polarization and secretion of their proinflammatory hallmark cytokines interleukin 6 (IL-6), IL-17, interferon γ, and tumor necrosis factor α, and an impaired CD4<jats:sup>+</jats:sup> CD25<jats:sup><jats:italic>high</jats:italic></jats:sup> FoxP3<jats:sup>+</jats:sup> regulatory T cell function. To restrain inflammation, VKH is pharmacologically treated with corticosteroids and immunosuppressive drugs as first and second line of therapy, respectively. Changes in the expression of miRNAs related to immunoregulatory pathways have been associated with VKH development, whereas some genetic variants of miRNAs have been found to be risk modifiers of VKH. Furthermore, the drugs commonly used in VKH treatment have great influence on miRNA expression, including those miRNAs associated to VKH disease. This relationship between response to therapy and miRNA regulation suggests that these small noncoding molecules might be therapeutic targets for the development of more effective and specific pharmacological therapy for VKH. In this review, we discuss the latest evidence regarding regulation and alteration of miRNA associated with VKH disease and its treatment.</jats:p>4Scopus© Citations 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Refractory systemic juvenile idiopathic arthritis successfully treated with rapamycin(2021) ;Sara Concha ;Emma Rey-Jurado ;M Cecilia Poli ;Rodrigo Hoyos-BachilogluArturo BorzutzkyScopus© Citations 6 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease(2020); ;María Paz Poblete De La FuenteElisa Catalina Parra Cancino3 1Scopus© Citations 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 18 5 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Diagnosis and classification of optic neuritis(2022) ;Axel Petzold ;Clare L Fraser ;Mathias Abegg ;Raed AlroughaniDaniah AlshowaeirScopus© Citations 81 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis(2022) ;Astrid M. van Huizen ;Stef P. Menting ;Rolland Gyulai ;Lars IversenGayle E. van der Kraaij40Scopus© Citations 19 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Clinical Outcome and Histological Findings After Induced Leakage of PMMA Loaded With Methotrexate and Cisplatin During Vertebroplasty: Experimental Model in Pigs(2021) ;Silva González, Alvaro ;Rafael Llombart-Blanco ;Gallegos Angulo, Marcela ;Carlos Villas ToméMatías Alfonso Olmos-García<jats:sec><jats:title>Study Design:</jats:title><jats:p> Animal experimental model. </jats:p></jats:sec><jats:sec><jats:title>Objective:</jats:title><jats:p> To study the clinical behavior and histological changes in the spinal cord, nerve roots and perivertebral muscles of the spine after induced leakage of polymethylmethacrylate (PMMA) loaded with antiblastic drugs during vertebroplasty in an animal model of pigs. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> We performed vertebroplasty on 25 pigs. The animals were divided into 3 groups: vertebroplasty with PMMA alone (control group), vertebroplasty with PMMA loaded with methotrexate (MTX) and vertebroplasty with PMMA loaded with cisplatin (CYS). At 2 vertebral levels, epidural and prevertebral, massive cement leaks were induced. Animals were evaluated daily. Two weeks later, the pigs were sacrificed, and the tissues that came in contact with the cement were analyzed. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> The clinical results for each of the groups were reported. The control group had no clinical alterations. In the MTX group, 2 pigs died before 1 week due to pneumonitis. In the CYS group, 4 animals had motor impairment, and 3 of the 4 had paraplegia. The histological results were as follows: the control and MTX groups showed synovial metaplasia, inflammatory reaction, crystal deposits, and giant cell reaction in the dura mater and muscle and all the animals in the CYS group had spinal cord and muscular necrosis. </jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p> Massive cement leak after vertebroplasty with PMMA loaded with cisplatin is extremely toxic to the spinal cord and muscles around the spine. Therefore, its use cannot be recommended for the treatment of vertebral metastases. Using PMMA loaded with methotrexate seems to be a safe procedure, but further research is needed. </jats:p></jats:sec>6Scopus© Citations 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview(2020) ;Rodrigo A. Valenzuela ;Iván Flores ;Beatriz Urrutia ;Francisca FuentesPablo E. SabatScopus© Citations 28 2